These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7586084)

  • 1. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
    Uchida T; Yoshida K; Ninomiya A; Goto S
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method.
    Uchida T; Nagareya N; Sakakibara S; Konishi Y; Nakai A; Nishikata M; Matsuyama K; Yoshida K
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1539-43. PubMed ID: 9332006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
    Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
    J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
    Uchida T; Yoshida K; Goto S
    J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres.
    Cavalier M; Benoit JP; Thies C
    J Pharm Pharmacol; 1986 Apr; 38(4):249-53. PubMed ID: 2872287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
    Yang YY; Chia HH; Chung TS
    J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
    Coombes AG; Yeh MK; Lavelle EC; Davis SS
    J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K; Muramatsu N; Kondo T
    J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
    Chen W; Lu DR
    J Microencapsul; 1999; 16(5):551-63. PubMed ID: 10499836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of water-soluble drugs in PLGA microspheres.
    Ito F; Fujimori H; Makino K
    Colloids Surf B Biointerfaces; 2007 Feb; 54(2):173-8. PubMed ID: 17137764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
    Iwata M; McGinity JW
    J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-loaded PLA and PLGA microspheres: in vitro evaluation.
    Filipović-Grcić J; Crc V; Jalsenjak I
    Boll Chim Farm; 1999 Jan; 138(1):14-8. PubMed ID: 10326310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
    Fu X; Ping Q; Gao Y
    J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.